E Mor

Summary

Country: Israel

Publications

  1. ncbi Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation
    E Mor
    Rabin Medical Center, Petah Tikva, Israel
    Ann Intern Med 129:643-53. 1998
  2. ncbi Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation
    Z Ben-Ari
    The Liver Institute, Department of Medicine D, Rabin Medical Center, Beilinson Campus, PO Box 102, Petah Tiqva 49100, Israel
    Liver Transpl 7:113-7. 2001
  3. ncbi Association of post-liver transplantation diabetes mellitus with hepatitis C virus infection
    H Schmilovitz-Weiss
    Gastroenterology Unit, Rabin Medical Center, Petah Tikva, Israel
    Transplant Proc 35:667-8. 2003
  4. ncbi Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature
    Z Ben-Ari
    Liver Institute and Department of Medicine D, Rabin Medical Center, Beilinson Campus, Sackler School of Medicine, Tel Aviv University, Petah Tikva, Israel
    J Intern Med 253:544-52. 2003
  5. ncbi Defibrotide for the treatment of veno-occlusive disease after liver transplantation
    E Mor
    Department of Transplantation, Rabin Medical Center, Beilinson Campus, Petah Tiqva 49 100, Israel
    Transplantation 72:1237-40. 2001
  6. ncbi Rejection rate in living donor kidney transplantation with and without basiliximab in tacrolimus/mycophenolate mofetil-based protocol
    R Rahamimov
    Department of Transplantation, Rabin Medical Center, Beilinson Campus, Petah Tiqwa, Israel
    Transplant Proc 35:653-4. 2003
  7. ncbi Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantation
    Z Ben-Ari
    The Liver Institute, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
    Transplant Proc 35:612-3. 2003
  8. doi Magnetic resonance cholangiopancreatography for the accurate diagnosis of biliary complications after liver transplantation: comparison with endoscopic retrograde cholangiography and percutaneous transhepatic cholangiography - long-term follow-up
    L H Katz
    Liver Institute and Department of Medicine D, Rabin Medical Center, Petah Tikva, Israel
    Clin Transplant 24:E163-9. 2010
  9. ncbi De novo tumors after liver transplantation: a single-center experience
    H Schmilovitz-Weiss
    Gastroenterology Unit, Rabin Medical Center, Petah Tiqva, Israel
    Transplant Proc 35:665-6. 2003
  10. doi Mucormycosis in a liver allograft: salvage re-transplantation and targeted immunosuppressive management
    M Gurevich
    Department of Transplantation, Rabin Medical Center, Beilinson Hospital, Petach Tiqwa, Israel
    Transpl Infect Dis 14:E97-101. 2012

Collaborators

Detail Information

Publications25

  1. ncbi Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation
    E Mor
    Rabin Medical Center, Petah Tikva, Israel
    Ann Intern Med 129:643-53. 1998
    ..To review the treatment of cirrhotic patients with hepatocellular carcinoma in the era of liver transplantation and to determine the most appropriate approach to the treatment of patients at different stages of disease...
  2. ncbi Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation
    Z Ben-Ari
    The Liver Institute, Department of Medicine D, Rabin Medical Center, Beilinson Campus, PO Box 102, Petah Tiqva 49100, Israel
    Liver Transpl 7:113-7. 2001
    ....
  3. ncbi Association of post-liver transplantation diabetes mellitus with hepatitis C virus infection
    H Schmilovitz-Weiss
    Gastroenterology Unit, Rabin Medical Center, Petah Tikva, Israel
    Transplant Proc 35:667-8. 2003
  4. ncbi Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature
    Z Ben-Ari
    Liver Institute and Department of Medicine D, Rabin Medical Center, Beilinson Campus, Sackler School of Medicine, Tel Aviv University, Petah Tikva, Israel
    J Intern Med 253:544-52. 2003
    ..To analyse the results of lamivudine therapy on suppression of hepatitis B virus (HBV) replication before transplantation and on preventing graft reinfection postoperatively...
  5. ncbi Defibrotide for the treatment of veno-occlusive disease after liver transplantation
    E Mor
    Department of Transplantation, Rabin Medical Center, Beilinson Campus, Petah Tiqva 49 100, Israel
    Transplantation 72:1237-40. 2001
    ..Neither patient had side effects from the drug. CONCLUSIONS: Defibrotide is a promising drug for the treatment of VOD after liver transplantation and needs to be evaluated in large, prospective studies...
  6. ncbi Rejection rate in living donor kidney transplantation with and without basiliximab in tacrolimus/mycophenolate mofetil-based protocol
    R Rahamimov
    Department of Transplantation, Rabin Medical Center, Beilinson Campus, Petah Tiqwa, Israel
    Transplant Proc 35:653-4. 2003
  7. ncbi Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantation
    Z Ben-Ari
    The Liver Institute, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
    Transplant Proc 35:612-3. 2003
  8. doi Magnetic resonance cholangiopancreatography for the accurate diagnosis of biliary complications after liver transplantation: comparison with endoscopic retrograde cholangiography and percutaneous transhepatic cholangiography - long-term follow-up
    L H Katz
    Liver Institute and Department of Medicine D, Rabin Medical Center, Petah Tikva, Israel
    Clin Transplant 24:E163-9. 2010
    ..We recommend that MRCP be the diagnostic imaging modality of choice in this setting, reserving direct cholangiography for therapeutic procedures...
  9. ncbi De novo tumors after liver transplantation: a single-center experience
    H Schmilovitz-Weiss
    Gastroenterology Unit, Rabin Medical Center, Petah Tiqva, Israel
    Transplant Proc 35:665-6. 2003
  10. doi Mucormycosis in a liver allograft: salvage re-transplantation and targeted immunosuppressive management
    M Gurevich
    Department of Transplantation, Rabin Medical Center, Beilinson Hospital, Petach Tiqwa, Israel
    Transpl Infect Dis 14:E97-101. 2012
    ..At 3-year follow-up, the child maintained normal graft function. We conclude that discontinuation of immunosuppression combined with a modern antifungal regimen may allow salvage re-transplantation in patients with liver mucormycosis...
  11. ncbi Switching from tacrolimus to sirolimus halts the appearance of new sebaceous neoplasms in Muir-Torre syndrome
    Z Levi
    Department of Gastroenterology, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel
    Am J Transplant 7:476-9. 2007
    ..Further studies on the potential use of sirolimus for the treatment of de novo tumors in immunosuppressed kidney transplant recipients with HNPCC are warranted...
  12. ncbi Extension of the organ pool in kidney transplantation: first year experience of the Israel Transplant Center
    E Mor
    Department of Transplantation, Rabin Medical Center, Petah Tiqva, Israel
    Isr Med Assoc J 2:302-5. 2000
    ..Over a 12 month period, the Israel Transplant Center doubled the number of donors by assigning a nurse coordinator to each of 22 hospitals around the country and by using kidneys from elderly donors...
  13. ncbi Cholestasis and hypoalbuminemia as predictors of outcome after liver transplantation
    E Mor
    Department of Transplantation, Petah Tikwa, Israel
    Transplant Proc 35:617-8. 2003
  14. doi Consequences of treated versus untreated asymptomatic bacteriuria in the first year following kidney transplantation: retrospective observational study
    H Green
    Department of Nephrology and Hypertension, Rabin Medical Center, Beilinson Campus, Petah Tikva 49100, Israel
    Eur J Clin Microbiol Infect Dis 32:127-31. 2013
    ..We observed no benefit for the antibiotic treatment of AB in the short- and long-term follow-up. A prospective observational study is needed...
  15. ncbi Cathepsin B inactivation attenuates the apoptotic injury induced by ischemia/reperfusion of mouse liver
    Z Ben-Ari
    Liver Institute and Department of Medicine D, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
    Apoptosis 10:1261-9. 2005
    ..The aim of this study was to ascertain if cathepsin B inactivation attenuates the apoptotic injury due to I/R in mouse liver...
  16. ncbi BK polyoma virus nephropathy in kidney transplant recipient: the role of new immunosuppressive agents
    R Rahamimov
    Department of Nephrology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
    Transplant Proc 35:604-5. 2003
  17. ncbi Percutaneous balloon dilatation for the treatment of early and late ureteral strictures after renal transplantation: long-term follow-up
    Gil N Bachar
    Department of Radiology, Interventional Radiology Unit, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
    Cardiovasc Intervent Radiol 27:335-8. 2004
    ..PBD is a safe and simple tool for treating ureteral strictures and procedure-related morbidity is low. It can serve as an initial treatment in patients with early or late ureteral strictures after renal transplantation...
  18. ncbi Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients
    Z Ben-Ari
    Liver Institute, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
    Transplant Proc 35:609-11. 2003
  19. ncbi Parenteral fish oil administered to heart-beating organ donors and to renal transplant recipients: effects on renal function
    V Zolotarski
    Department of General Intensive Care, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel
    Transplant Proc 35:624. 2003
  20. ncbi The role of nutritional support in transplant recipients: two case reports
    R Anbar
    Department of Nutrition, Petah Tiqwa, Israel
    Transplant Proc 35:614-6. 2003
  21. ncbi Preliminary results of non-cross-matched "old for old" kidney transplantation
    R Rahamimov
    Nephrology Committee Israel Transplant Organization, Petah Tiqva, Israel
    Transplant Proc 35:647-8. 2003
  22. ncbi Mucormycosis of the renal allograft: case report and review of the literature
    A Chkhotua
    Institute of Urology, Tbilisi, Georgia
    Transpl Int 14:438-41. 2001
    ..Fungal colonization may occur during transplantation. A high index of suspicion, leading to early diagnosis and initiation of antifungal treatment, in addition to graft nephrectomy, are keys to a more favorable outcome...
  23. ncbi Primary hyperoxaluria type 1: improved outcome with timely liver transplantation: a single-center report of 36 children
    R Shapiro
    Pediatric Gastroenterology and Nephrology Units, Schneider Children's Medical Center, Petach-Tikva, 49100, Israel
    Transplantation 72:428-32. 2001
    ..Combined liver-kidney transplantation is suggested for children with end-stage renal disease...
  24. ncbi Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children
    R Shapira
    Pediatric Gastroenterology Institute, Schneider Children's Medical Center of Israel, Petah Tiqva, Israel
    Transplantation 72:333-6. 2001
    ..No adverse effects of the drug were noted. CONCLUSION: Lamivudine is beneficial and well tolerated in children with HBV infection after liver transplantation...
  25. ncbi Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients
    A R Tambur
    Department of Immunology, 1577 Jelke, Rush Medical College, 1653 W Congress Parkway, Chicago, IL 60612, USA
    Transplantation 71:1475-80. 2001
    ..The objective of this study was to analyze the role of cytokine allelic variations in susceptibility to early graft rejection episodes and recurrence of hepatitis C infection in liver transplant (LTx) recipients...